CVS Health Corporate Other — Net investment income decreased by 9.2% to $109.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 55.7%, from $70.00M to $109.00M. Over 3 years (FY 2021 to FY 2025), Corporate Other — Net investment income shows a downward trend with a -10.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests better returns on corporate cash or a larger investment base, while a decrease may indicate lower yields or reduced investment assets.
This represents the income generated from the investment portfolio held by the corporate segment, typically derived from...
Common in insurance and diversified healthcare firms with significant float or corporate treasury assets.
cvs_segment_corporate_other_net_investment_income| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.00M | $149.00M | $149.00M | $110.00M | $173.00M | $68.00M | $92.00M | $61.00M | $101.00M | $96.00M | $128.00M | $70.00M | $119.00M | $83.00M | $120.00M | $109.00M |
| QoQ Change | — | +0.0% | +0.0% | -26.2% | +57.3% | -60.7% | +35.3% | -33.7% | +65.6% | -5.0% | +33.3% | -45.3% | +70.0% | -30.3% | +44.6% | -9.2% |
| YoY Change | — | — | — | -26.2% | — | — | -16.4% | — | -41.6% | +41.2% | +39.1% | +14.8% | +17.8% | -13.5% | -6.3% | +55.7% |